EFFECT OF PRIOR CHEMOTHERAPY ON BIOLOGIC RESPONSE MODIFIER ACTIVITY

被引：0
|
作者：
WEISENTHAL, LM
机构：
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1991年 / 83卷 / 11期
关键词：
D O I：
10.1093/jnci/83.11.790
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：790 / 791
页数：2
相关论文
共 50 条
  • [1] EFFECT OF PRIOR CHEMOTHERAPY ON BIOLOGIC RESPONSE MODIFIER ACTIVITY - REPLY
    KOVACH, JS
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (11) : 791 - 793
  • [2] Economic evaluation of biologic response modifier specialty pharmacy prior authorization program
    Sun, S. X.
    Razavi, E.
    Patel, B.
    Meridor, N.
    Lee, K. Y.
    [J]. VALUE IN HEALTH, 2007, 10 (03) : A120 - A120
  • [3] KINETICS OF THE BIOLOGIC RESPONSE IN MAN OF INTERFERON, A BIOLOGIC RESPONSE MODIFIER
    BAROUKI, FM
    WITTER, FR
    GRIFFIN
    NADLER, PI
    WOOD, DL
    LIETMAN, PS
    LIETMAN, BS
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (02) : 180 - 180
  • [4] BRYOSTATIN-1, A UNIQUE BIOLOGIC RESPONSE MODIFIER - ANTILEUKEMIC ACTIVITY INVITRO
    JONES, RJ
    SHARKIS, SJ
    MILLER, CB
    ROWINSKY, EK
    BURKE, PJ
    MAY, WS
    [J]. BLOOD, 1990, 75 (06) : 1319 - 1323
  • [5] EFFECT OF PRIOR CANCER-CHEMOTHERAPY ON HUMAN TUMOR-SPECIFIC CYTOTOXICITY INVITRO IN RESPONSE TO IMMUNOPOTENTIATING BIOLOGIC RESPONSE MODIFIERS
    WEISENTHAL, LM
    DILL, PL
    PEARSON, FC
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (01) : 37 - 42
  • [6] SCUTELLARIA-BAICALENSIS AS BIOLOGIC RESPONSE MODIFIER
    UDINTSEV, SN
    RAZINA, TG
    YAREMENKO, KV
    [J]. VOPROSY ONKOLOGII, 1990, 36 (05) : 602 - 607
  • [7] Biologic response modifier therapy for psoriatic ocular inflammatory disease
    Huynh, Nancy
    Cervantes-Castaneda, Rene A.
    Bhat, Pooja
    Gallagher, Michael J.
    Foster, C. Stephen
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2008, 16 (03) : 89 - 93
  • [8] Etanercept (Enbrel) - Biologic response modifier to treat rheumatoid arthritis
    不详
    [J]. AMERICAN JOURNAL OF NURSING, 1999, 99 (02) : 60 - 60
  • [9] Tofacitinib as a biologic response modifier in VEXAS syndrome: A case series
    Salehi, Tania
    Callisto, Alicia
    Beecher, Mark Brian
    Hissaria, Pravin
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (11) : 2340 - 2343
  • [10] IMMUNOPOTENTIATING PROPERTIES OF THE BIOLOGIC RESPONSE MODIFIER - NONTOXIC MONOPHOSPHORYL LIPID A
    RIBI, E
    CANTRELL, JL
    SCHWARTZMAN, SM
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 235 - 235
12345